Galmed Pharmaceuticals (GLMD) FCF Margin (2016 - 2018)
Galmed Pharmaceuticals (GLMD) recorded quarterly FCF Margin of 120.6% in Q3 2018, up 77.5% quarter-over-quarter from 535.93% in Q2 2018, and up 93874.0% on a YoY basis from N/an in Q3 2017.
Galmed Pharmaceuticals (GLMD) FCF Margin (2016 - 2018) Analysis & Trends
Galmed Pharmaceuticals' FCF Margin history runs 3 years deep, the most recent figure standing at 120.6% for Q3 2018.
- In Q3 2018, FCF Margin rose 93874.0% year-over-year to 120.6%; the TTM figure through Jun 2019 stood at 622.66% (up 32527.0% YoY), while the FY2018 annual figure was 438.32%, up 67274.0% from the prior year.
- FCF Margin was 120.6% for Q3 2018 at Galmed Pharmaceuticals, up from 535.93% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 120.6% in Q3 2018 to a low of 1662.69% in Q3 2016.
- Historically, FCF Margin has averaged 1010.67% across 3 years, with a median of 1042.22% in 2017.
- The sharpest annual moves came in 2017 and 2018: FCF Margin surged 12810 bps in 2017, then soared 93874 bps in 2018.
- A 3-year view of FCF Margin shows it stood at 1033.94% in 2016, then rose by 12 bps to 905.84% in 2017, then jumped by 87 bps to 120.6% in 2018.
- The last three FCF Margin figures came in at 120.6% (Q3 2018), 535.93% (Q2 2018), and 1292.54% (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -120.60% |
| Jun 30, 2018 | -535.93% |
| Mar 31, 2018 | -1,292.54% |
| Dec 31, 2017 | -905.84% |
| Sep 30, 2017 | -1,059.34% |
| Jun 30, 2017 | -1,042.22% |
| Mar 31, 2017 | -1,442.91% |
| Dec 31, 2016 | -1,033.94% |
| Sep 30, 2016 | -1,662.69% |